Non-executive board

Board of directors

Board of directors

Herbert Heyneker - Chairman

Herbert Heyneker - Chairman of the Board
  • Biotech business pioneer
  • Entrepreneur
  • Innovator

After earning his PhD from Leiden University in Holland, Herbert Heyneker moved in 1975 to San Francisco to take a postdoc in Herbert Boyer’s UCSF lab where he was involved in gene splicing and somatostatin research. Soon afterward, he joined Genentech as one of the company’s first scientists. In 1984 he moved to Genencor, Genentech spinoff to become VP of R&D. He has held positions with Eos Biotechnology, ProtoGene Laboratories, GlycoGen and Genencor. He also served on the board of directors for GenPharm and Guava Technologies in the US and in the Netherlands, IntroGene (acquired by Crucell), Pharming, Pepscan and Prosensa. He is an author on more than 50 peer-reviewed papers and an inventor on more than 30 US patents.

André Hoekema - Member

André Hoekema - Board Member
  • Pharma dealmaker
  • Corporate biotech business
  • Sales and distribution

Dr. Hoekema is Senior Vice President Corporate Development of Galapagos since March 2005. He joined Galapagos from Invitrogen Corporation, where he was Managing Director of Corporate Development Europe. He brings 20 years of biotech experience from positions at Molecular Probes Europe (Managing Director), Crucell (Director of Business Development), DSM Life Sciences and MOGEN (Research and Project Management) and Genentech, Inc (R&D). Dr. Hoekema has a PhD degree from Leiden University and is the inventor of over 20 series of patent applications, resulting in 15 patents issued in the US.

Bart Bergstein - Member

Bart Bergstein - Board Member
  • Biotech venture capital
  • Corporate finance
  • Banking

Bart started his career at ABN AMRO in 1990 and held several postings in the Netherlands and abroad. In 1997 he joined the private equity department of ABN AMRO where he founded the life sciences team in 2000. He was head of the life sciences department until the spin out of the team in 2006, forming Forbion Capital Partners. Bart is one of the founders of Forbion. He has 15 years of experience in venture capital and has broad transactional and management experience. Bart serves currently on the board of several life sciences companies. Furthermore Bart is Vice President of the managing board of the Mibiton Foundation, a government backed foundation providing soft loans to early stage life sciences companies. Bart holds a masters degree in construction engineering from the Technical University of Eindhoven.